Filed: 2/14/2023ACC: 0001104659-23-021612
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 34 equity positions with a total reported market value of $162.50M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
34
Positions
$162.50M
Total AUM (reported)
11.52M
Total Shares
Allocation by class
COM$142.81M87.9%
COM NEW$12.26M7.5%
ORDINARY SHARES$2.36M1.5%
SPONSORED ADR$1.93M1.2%
SHS$1.24M0.8%
CLASS A ORD$981.8K0.6%
COMMON STOCK$896.7K0.6%
Portfolio Concentration
Top 3$42.45M26.1%
4–10$59.59M36.7%
11–25$55.26M34.0%
Rest$5.20M3.2%
Top 3 weight
26.1%
Top 10 weight
62.8%
Voting Authority Distribution
Total shares with voting rights: 11.52M
Sole
Full voting authority
11.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole34
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings34
Rows:
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$19.62M
12.08%
Sole
1.85M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares396.50K
TypeSH
Market value$11.58M
7.13%
Sole
396.50K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares217.50K
TypeSH
Market value$11.25M
6.92%
Sole
217.50K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$11.20M
6.89%
Sole
1.10M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares33K
TypeSH
Market value$9.18M
5.65%
Sole
33K
Shared
0.00
None
0.00
SAREPTA TEHRAPEUTICS INC
SOLEShares67.50K
TypeSH
Market value$8.75M
5.38%
Sole
67.50K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares324.61K
TypeSH
Market value$8.26M
5.08%
Sole
324.61K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares360.50K
TypeSH
Market value$7.72M
4.75%
Sole
360.50K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares290.50K
TypeSH
Market value$7.56M
4.65%
Sole
290.50K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares144.50K
TypeSH
Market value$6.93M
4.26%
Sole
144.50K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC. COMMON STOCK
SOLEShares1.01M
TypeSH
Market value$6.36M
3.92%
Sole
1.01M
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares501.50K
TypeSH
Market value$6.22M
3.83%
Sole
501.50K
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares950K
TypeSH
Market value$5.57M
3.43%
Sole
950K
Shared
0.00
None
0.00
BELLUS HEALTH INC
SOLEShares632.50K
TypeSH
Market value$5.20M
3.20%
Sole
632.50K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares115K
TypeSH
Market value$5.13M
3.15%
Sole
115K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares260K
TypeSH
Market value$5.09M
3.13%
Sole
260K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares500K
TypeSH
Market value$4.13M
2.54%
Sole
500K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS
SOLEShares255K
TypeSH
Market value$4.02M
2.47%
Sole
255K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares80K
TypeSH
Market value$3.84M
2.36%
Sole
80K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares243.25K
TypeSH
Market value$2.36M
1.45%
Sole
243.25K
Shared
0.00
None
0.00
ARGEN SE
SOLEShares5.10K
TypeSH
Market value$1.93M
1.19%
Sole
5.10K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC
SOLEShares41.03K
TypeSH
Market value$1.66M
1.02%
Sole
41.03K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares185K
TypeSH
Market value$1.35M
0.83%
Sole
185K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares154.47K
TypeSH
Market value$1.34M
0.83%
Sole
154.47K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares303.40K
TypeSH
Market value$1.06M
0.65%
Sole
303.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $19.62M 12.08% | 1.85M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 396.50K | SH | $11.58M 7.13% | 396.50K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 217.50K | SH | $11.25M 6.92% | 217.50K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $11.20M 6.89% | 1.10M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 33K | SH | $9.18M 5.65% | 33K | 0.00 | 0.00 |
SAREPTA TEHRAPEUTICS INCSOLE | COM | 67.50K | SH | $8.75M 5.38% | 67.50K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 324.61K | SH | $8.26M 5.08% | 324.61K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 360.50K | SH | $7.72M 4.75% | 360.50K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 290.50K | SH | $7.56M 4.65% | 290.50K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 144.50K | SH | $6.93M 4.26% | 144.50K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INC. COMMON STOCKSOLE | COM | 1.01M | SH | $6.36M 3.92% | 1.01M | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 501.50K | SH | $6.22M 3.83% | 501.50K | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 950K | SH | $5.57M 3.43% | 950K | 0.00 | 0.00 |
BELLUS HEALTH INCSOLE | COM NEW | 632.50K | SH | $5.20M 3.20% | 632.50K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 115K | SH | $5.13M 3.15% | 115K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 260K | SH | $5.09M 3.13% | 260K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 500K | SH | $4.13M 2.54% | 500K | 0.00 | 0.00 |
ACLARIS THERAPEUTICSSOLE | COM | 255K | SH | $4.02M 2.47% | 255K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 80K | SH | $3.84M 2.36% | 80K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 243.25K | SH | $2.36M 1.45% | 243.25K | 0.00 | 0.00 |
ARGEN SESOLE | SPONSORED ADR | 5.10K | SH | $1.93M 1.19% | 5.10K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INCSOLE | COM | 41.03K | SH | $1.66M 1.02% | 41.03K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 185K | SH | $1.35M 0.83% | 185K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 154.47K | SH | $1.34M 0.83% | 154.47K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 303.40K | SH | $1.06M 0.65% | 303.40K | 0.00 | 0.00 |
Page 1 of 2